SDL-001 / Synthetic Design Lab - LARVOL DELTA

A Study to Investigate How Well an Intracolonic Formulation of Two Monoclonal Antibodies is Tolerated in Healthy Participants and the Ability for the Antibodies to be Taken up by the Body Via the Colon (clinicaltrials.gov) - P1 | N=18 | Not yet recruiting | Sponsor: Surmount Services, Inc.

New P1 trial